Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
(NY:
DNA
)
8.090
UNCHANGED
Official Closing Price
Updated: 7:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
17
18
Next >
3 Key Biotech Trends for 2023 And Beyond
↗
May 19, 2023
New opportunities are becoming apparent, but so are fresh risks in the biotech field.
Via
The Motley Fool
Ginkgo Bioworks Q1 Sales Beat Expectations, But Analyst Downgrades Stock On Guidance Concerns
↗
May 11, 2023
Ginkgo Bioworks Holdings Inc (NYSE: DNA) reported Q1 sales of $80.70 million, beating the consensus of $71.68 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
↗
May 11, 2023
Via
Benzinga
Disney, Sonos, Desktop Metal And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
May 11, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Sonos, Inc. (NASDAQ: SONO) shares dipped 25.2% to $15.82 in pre-market...
Via
Benzinga
Ginkgo Bioworks Holdings: Q1 Earnings Insights
↗
May 10, 2023
Via
Benzinga
Earnings Preview: Ginkgo Bioworks Holdings
↗
May 09, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
↗
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
After-Hours Action: Why Ginkgo Bioworks Stock Is Sliding
↗
May 10, 2023
Shares of cell programming platform company Ginkgo Bioworks Holdings Inc (NYSE: DNA) are moving lower after hours on the heels of a wider-than-expected quarterly loss.&nbs
Via
Benzinga
DNA Stock Earnings: Ginkgo Bioworks Misses EPS, Beats Revenue Estimates
↗
May 10, 2023
DNA stock earnings show Ginkgo Bioworks missing analyst estimates for its loss per share but beating revenue estimates.
Via
InvestorPlace
Down 76% From Its High, Can Ginkgo Bioworks Stock Turn Things Around?
↗
May 04, 2023
Ginkgo is coming off a strong performance in 2022, but this year will no doubt be a more challenging one for the business.
Via
The Motley Fool
7 Best Cathie Wood Stocks for Your May 2023 Buy List
↗
May 02, 2023
This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent.
Via
InvestorPlace
Despite Its Falling 92%, Cathie Wood Is Buying More of This Growth Stock
↗
May 01, 2023
Wood is betting that Ginkgo Bioworks' biofoundry can scale up enough to become profitable.
Via
The Motley Fool
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
↗
April 27, 2023
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present...
Via
Talk Markets
Ginkgo Bioworks Holdings's Earnings: A Preview
↗
February 28, 2023
Via
Benzinga
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Investor Notice: Investigation over Potential Wrongdoing
↗
April 25, 2023
San Diego, CA -- (SBWIRE) -- 04/25/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Ginkgo Bioworks Holdings, Inc..
Via
SBWire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
April 21, 2023
The growth-focused money manager is making moves.
Via
The Motley Fool
Cathie Wood Bets Big On Roblox With $19.5M Purchase — Also Loads Up On This Biotech Stock
↗
April 17, 2023
Via
Benzinga
5 Penny Stocks With Explosive 5X Potential
↗
April 17, 2023
Penny stocks are inherently risky, but investing in low-priced companies with wide "moats" can shift the odds in investors' favor.
Via
InvestorPlace
3 Growth Stocks to Buy for 100% Returns
↗
April 11, 2023
These three growth stocks to buy could provide triple-digit percentage returns for investors in the near to mid term.
Via
InvestorPlace
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
↗
April 06, 2023
Via
Benzinga
This Growth Stock Is Down 63% in 1 Year. Here's Why You Should Buy the Dip and Hold It for 5 Years
↗
March 29, 2023
The bear market hasn't been kind, but the future could be a lot better.
Via
The Motley Fool
Bragar Eagel & Squire is Investigating Certain Officers and Directors of C3.ai, Ginkgo Bioworks, and Polished on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 27, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
GINKGO BIOWORKS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ginkgo Bioworks Holdings, Inc. - DNA
March 25, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Luminar Technologies, EHang Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
March 22, 2023
U.S. stock futures traded slightly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Evogene Offers An Excellent Risk/Reward Ratio
↗
March 21, 2023
We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their...
Via
Talk Markets
7 Penny Stocks With Massive Growth Potential
↗
March 20, 2023
If you laugh at red ink, these tempting ideas just might be for you.
Via
InvestorPlace
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
↗
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Buy the Dip: 2 Exceptional Growth Stocks to Grab Before the Next Bull Market
↗
March 05, 2023
Now's the time to load up on stocks that got dented in the bear market.
Via
The Motley Fool
GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 01, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
February 28, 2023
From
Cronos Group Inc.
Via
GlobeNewswire
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
